Pfizer CEO Sells Stock Same Day Positive Results of COVID-19 Vaccine Announced
Story Highlights On Nov. 9, 2020, Pfizer released preliminary Phase 3 clinical trial data indicating that its experimental mRNA COVID-19 vaccine is 90 percent effective, triggering a big surge in stock price. Pfizer CEO Albert…
CONTINUE READINGOnly Half of Americans Polled Say They Would Get COVID-19 Vaccine
In a poll conducted for CNN during Oct. 1-4, 2020, the Pennsylvania-based market research firm SSRS found that 51 percent of…
Polls Find Many Americans Do Not Want COVID-19 Vaccine as Soon as It’s Licensed
Story Highlights More adults in the U.S. are expressing doubts about the safety of a newly licensed COVID-19 vaccine that…
Makers of Experimental COVID-19 Vaccines Lobby EU for Liability Protection
Vaccines Europe, a pharmaceutical industry lobbying group, has issued a memo to its member companies saying it would seek liability…
Novartis Pays $678 Million for Kickbacks to Doctors
Novartis Pharmaceuticals Corp. of East Hanover, New Jersey has agreed to pay $678 million to settle a civil fraud lawsuit…
Who is Getting Rich Off Coronavirus Pandemic?
Opinion | In May 2020, the U.S. unemployment rate was 13.3%,1 which means 21 million Americans were unemployed. Not surprisingly, financial…
Genetically Engineered Cow Plasma Therapy for COVID-19 Will Be Tested on Humans
Story Highlights Human trials for a new COVID-19 immunotherapy candidate (SAB-185) that is derived from genetically engineered cow plasma will…